Increased IL-4 mRNA expression and poly-aromatic hydrocarbon concentrations from children with asthma

Nasser M Al-Daghri1, Sherif Abd-Alrahman, Hossam Draz

  • 1Biomarkers Research Program, Biochemistry Department, College of Science, King Saud University, PO Box, 2455, 11451 Riyadh, Saudi Arabia. aldaghri2011@gmail.com.

BMC Pediatrics
|January 24, 2014
PubMed

Insights

Pediatric asthma is linked to higher Interleukin-4 (IL-4) mRNA and serum levels, along with increased poly-aromatic hydrocarbon (PAH) exposure. PAH exposure in rats also elevated IL-4 mRNA, suggesting a role in asthma inflammation.

Area of Science:

  • Immunology
  • Environmental Health
  • Pediatrics

Background:

  • Asthma, a prevalent childhood illness, involves cytokine imbalances and environmental factors like poly-aromatic hydrocarbons (PAHs).
  • T helper cell-derived cytokines, particularly Interleukin-4 (IL-4), are implicated in asthma pathogenesis.
  • Poly-aromatic hydrocarbons (PAHs) are environmental pollutants recognized for their potential role in respiratory diseases.

Purpose of the Study:

  • To compare mRNA expression of IL-4, interferon-gamma (IFN-γ), and ACSL3 in children with and without asthma.
  • To correlate gene expression with serum levels of IL-4, IFN-γ, and PAHs.
  • To investigate the effect of PAH exposure on IL-4, IFN-γ, and ACSL3 gene expression in a rat model.

Main Methods:

  • Quantitative real-time PCR (qRTPCR) was used for gene expression analysis.
  • Serum cytokine and PAH levels were measured using multiplex immunoassay kits and High-Performance Liquid Chromatography (HPLC).
  • A rat model was utilized to study the in vivo effects of PAH exposure on gene expression.

Main Results:

  • Children with asthma showed significantly higher IL-4 mRNA expression and serum IL-4 levels compared to controls.
  • Elevated serum PAH concentrations were observed in asthmatic children, while IFN-γ levels were lower.
  • In rats, exposure to a model PAH (benzopyrene) significantly increased IL-4 mRNA expression by 2.6-fold.

Conclusions:

  • Elevated IL-4 mRNA and serum levels are associated with pediatric asthma.
  • Increased PAH exposure is linked to asthma in children.
  • PAH-induced IL-4 upregulation in animal models suggests a mechanism contributing to asthma-related inflammation.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40